Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MAPK1IP1L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | OR4E2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | POLR1A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ATG4D | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ATG7 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | HIST2H2AA3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | ZNF107 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PIANP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
mRNA | CPNE7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | CD44 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |